Results 26 - 50 from 89 for "biofarm"
-
Biofarm Bets on New Internally-Developed Products
01.06.2022
Romanian-held pharmaceutical products manufacturer Biofarm, the fifth largest player on this market by turnover, plans to add internally-developed products to its portfolio, especially as the company more
-
Biofarm Plans to Double Turnover in 5-10 Years
11.23.2021
Pharmaceutical manufacturer Biofarm Bucuresti plans to double turnover and focus more on exports in the coming years, according to Catalin Vicol, the company’s general manager. more
-
Biofarm Inaugurates Second Drug Plant In Bucharest In Over EUR35M Investment
11.02.2021
Pharmaceutical manufacturer Biofarm (BIO.RO) has inaugurated a new pharmaceutical manufacturing and testing facility in capital Bucharest, which entailed an investment of over EUR35 million. more
-
Biofarm Sees 8% Turnover Growth, 15% Profit Increase In 2017-2020 Period
10.27.2021
Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Wednesday said it registered an aggregate growth of 8% in turnover and of 15% in profit during 2017 – 2020 period. more
-
Pharmaceutical Manufacturer Biofarm Earmarks EUR10M for Investments in 2021
04.29.2021
Pharmaceutical manufacturer Biofarm (BIO.RO) has budgeted RON47.4 million (almost EUR10 million) for investments in 2021, most of which or about 70% will go towards equipping the new production more
-
Biofarm Cleared for RON21.7M Dividend Payout
04.26.2021
Shareholders of Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Monday approved the company's plans to distribute dividends totaling RON21.7 million. more
-
Biofarm Targets 15% Growth in Turnover in 2021, to RON250M
03.23.2021
Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) estimates its turnover will grow 15% in 2021 compared with 2020, to over RON250 million. more
-
Biofarm Net Profit Up 7.2% To RON54M, Sales Revenue Up 8% To RON218M YoY In 2020
02.16.2021
Biofarm Bucuresti (BIO.RO), one of the leading drugmakers in Romania, ended 2020 with a net profit of RON54.5 million, up 7.2% versus 2019, while income from sales grew 8% to RON218 million, the more
-
Marian Buica Elected Temporary Member Of Biofarm Board Of Directors
09.18.2020
Marian Buica, general manager of regional investment fund SIF Muntenia (SIF4.RO), was elected temporary member of the Board of Directors of pharmaceuticals company Biofarm, Bucuresti and is to be more
-
Biofarm Posts RON30M Net Profit in H1
08.17.2020
Pharmaceutical company Biofarm Bucuresti (BIO.RO) posted 29.8 million lei net profit in the first half, 6% higher than in the year-ago period, while revenue stood at RON106 million, up from the RON97 more
-
Biofarm Seeks To Pay Gross Dividends Of RON0.021/Share From 2019 Net Profit, At 6.3% Yield
03.24.2020
-
Biofarm Shareholders Approve Additional Dividends of RON9.8M
12.11.2019
Shareholders of pharmaceutical producer Biofarm (BIO.RO) on Wednesday approved additional dividends of RON0.01 per share, amounting to RON9.8 million. more
-
Biofarm Investments Exceed RON10M In January-June 2019
08.14.2019
-
SIF Moldova Sells All Its Shares In Biofarm To SIF Banat-Crisana
05.24.2019
-
Biofarm Net Profit Grows 46% in 1Q, to RON16.2M
05.15.2019
Romanian pharmaceutical producer Biofarm (BIO.RO) on Wednesday reported a net profit of RON16.2 million for the first quarter, up 46% compared with the same period last year. more
-
Biofarm Appoints Catalin Vicol as General Manager Starting Nov 15
09.13.2018
Romanian pharmaceutical producer Biofarm (BIO.RO), controlled by three regional investment funds, of SIFs, has appointed Catalin Vicol as general manager effective November 15. more
-
Biofarm Proposes RON18.7M Dividends At 6% Yield
03.14.2018
Romanian pharmaceutical producer Biofarm (BIO.RO) proposes the payment of a gross dividend of RON0.019 per share, at a 6.16% yield, totaling RON18.7 million, which translates into a distribution rate more
-
Biofarm 2017 Turnover Up 12% At RON170M; Net Profit Up 24% At RON36M
01.31.2018
-
SIF Banat-Crisana Increases Stake In Biofarm By 1.16%
09.21.2016
Romanian regional investment fund SIF Banat-Crisana (SIF1.RO) has recently bought a stake of 11.44 million shares of pharmaceutical producer Biofarm Bucuresti (BIO.RO), which represents 1.16% of the more
-
Biofarm Profit Up 1% To RON15.2M In 1H
08.12.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) reported a profit of RON15.2 million in the first six months of the year, up 1% compared with January-June 2015, the company said Friday. more
-
Biofarm Profit Drops 52% To RON6.5M In 1Q
05.17.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) reported a profit of RON6.49 million in the first quarter of the year, down 52% compared with January-March 2015, the company said on Tuesday. more
-
Biofarm Eyes RON150M Sales In 2016
05.04.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) targets sales of RON150.8 million, exploitation expenses of RON122 million and an operating profit of RON28.8 million this year. more
-
Biofarm Sales Up 16% To RON150M In 2015
02.16.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) reported sales of RON149.7 million (EUR33.7 million) in 2015, up 16% compared with RON128.9 million a year before, the company said in a statement. more
-
SIF Muntenia Is Biofarm’s Majority Stockholder On Ransomed Stake Cancelation
09.02.2015
Romanian regional investment fund SIF Muntenia (SIF4.RO) owns a stake of over 50% in Romanian pharmaceutical producer Biofarm (BIO.RO), on the company’s share capital decreasing after the more
-
SIF Banat-Crisana Buys 16% Stake In Biofarm
08.26.2015
Regional investment fund SIF Banat-Crisana (SIF1.RO) bought a 16.8% stake in Romanian pharmaceutical producer Biofarm (BIO.RO) for 51,000 lei, on the Bucharest Stock Exchange’s August 24 session, more